Max Drawdown (5Y) Chart

View Max Drawdown (5Y) for ARGX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Max Drawdown (5Y) Chart
Start Trial

Historical Max Drawdown (5Y) Data

View and export this data back to 2017. Start Trial.
Date Value
July 31, 2026 38.20%
June 30, 2026 38.20%
May 31, 2026 38.20%
April 30, 2026 38.20%
March 31, 2026 38.20%
February 28, 2026 38.20%
January 31, 2026 38.20%
December 31, 2025 38.20%
November 30, 2025 38.20%
October 31, 2025 38.20%
September 30, 2025 38.20%
August 31, 2025 38.20%
July 31, 2025 38.20%
June 30, 2025 38.20%
May 31, 2025 38.20%
April 30, 2025 38.20%
March 31, 2025 38.20%
February 28, 2025 38.20%
January 31, 2025 38.20%
December 31, 2024 38.20%
November 30, 2024 38.20%
October 31, 2024 38.20%
September 30, 2024 38.20%
August 31, 2024 38.20%
July 31, 2024 38.20%
Date Value
June 30, 2024 38.20%
May 31, 2024 38.20%
April 30, 2024 38.20%
March 31, 2024 38.20%
February 29, 2024 38.20%
January 31, 2024 38.20%
December 31, 2023 38.20%
November 30, 2023 34.13%
October 31, 2023 34.13%
September 30, 2023 36.29%
August 31, 2023 36.29%
July 31, 2023 36.29%
June 30, 2023 36.29%
May 31, 2023 36.29%
April 30, 2023 36.29%
March 31, 2023 36.29%
February 28, 2023 36.29%
January 31, 2023 36.29%
December 31, 2022 36.29%
November 30, 2022 36.29%
October 31, 2022 36.29%
September 30, 2022 36.29%
August 31, 2022 36.29%
July 31, 2022 36.29%
June 30, 2022 36.29%

Max Drawdown Definition

Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.

Read full definition.

Max Drawdown (5Y) Range, Past 5 Years

View Max Drawdown (5Y) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Max Drawdown (5Y) Benchmarks

View Max Drawdown (5Y) Benchmarks
Start Trial
Autolus Therapeutics Plc 96.58%
Akari Therapeutics Plc 99.83%
Forte Biosciences, Inc. 99.82%
Evaxion AS 99.79%
Grifols SA 77.82%